• Explore /
  • Poster
  • / Analysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC).

Analysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC).

Abstract Poster

Authors

MARIA ALSINA

Maria Alsina

Vall d'Hebron Institute of Oncology, Barcelona, Spain

Maria Alsina , Josep Tabernero , Kohei Shitara , Toshihiko Doi , Mikhail Dvorkin , Wasat Mansoor , Hendrik-Tobias Arkenau , Aliaksandr Prokharau , Michele Ghidini , Catia Faustino , Vera Gorbunova , Edvard Zhavrid , Kazuhiro Nishikawa , Takayuki Ando , Suayib Yalcin , Eric Van Cutsem , Donia Skanji , Catherine Leger , Javier Sabater , David H. Ilson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT02500043

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4043)

DOI

10.1200/JCO.2019.37.15_suppl.4043

Abstract #

4043

Poster Bd #

148

Abstract Disclosures

Similar Posters

First Author: Josep Tabernero

First Author: David H. Ilson

First Author: Kohei Shitara

First Author: Wasat Mansoor